Quinoxaline-containing compounds as hepatitis C virus inhibitors

Details for Australian Patent Application No. 2008322537 (hide)

Owner Enanta Pharmaceuticals, Inc.

Inventors Or, Yat Sun; Gai, Yonghua; Wang, Zhe

Agent Spruson & Ferguson

Pub. Number AU-A-2008322537

PCT Pub. Number WO2009/064975

Priority 61/025,458 01.02.08 US; 60/987,958 14.11.07 US

Filing date 14 November 2008

Wipo publication date 22 May 2009

International Classifications

A01N 43/60 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/064975 Priority application(s): WO2009/064975

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008322541-Method and apparatus for processing a pulsatile biometric signal

2008322523-Antibodies specific for the protofibril form of beta-amyloid protein